MedPath

Emcure Pharmaceuticals Ltd.

Emcure Pharmaceuticals Ltd. logo
🇮🇳India
Ownership
Public
Established
1983-01-01
Employees
10K
Market Cap
-
Website
http://www.emcure.com

Clinical Trials

20

Active:2
Completed:8

Trial Phases

3 Phases

Phase 1:8
Phase 4:2
Not Applicable:5

Drug Approvals

3

NMPA:2
FDA:1

Drug Approvals

Leflunomide Tablets

Product Name
来氟米特片
Approval Number
国药准字HJ20240074
Approval Date
Jul 30, 2024
NMPA

Leflunomide Tablets

Product Name
来氟米特片
Approval Number
国药准字HJ20240075
Approval Date
Jul 30, 2024
NMPA

Clinical Trials

Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials

Phase 1
8 (53.3%)
Not Applicable
5 (33.3%)
Phase 4
2 (13.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.